Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30695310 | 1.00 | HTR2A (0.39) | HTR2ANOTUMKDM1APDK2PDK4 | |
| SCHEMBL5694129 | 0.86 | HTR2A (0.35) | HTR2ANOTUMKDM1APDK2PDK4 | |
| SCHEMBL29548964 | 0.86 | HTR2A (0.35) | HTR2ANOTUMKDM1APDK2PDK4 | |
| SCHEMBL10819306 | 0.84 | HTR2A (0.34) | HTR2ANOTUMKDM1APDK2PDK4 | |
| SCHEMBL28357421 | 0.82 | HTR2A (0.33) | HTR2ANOTUMKDM1APDK2PDK4 | |
| SCHEMBL501768 | 0.81 | RXRA (0.42) | HTR2ANOTUMKDM1A | |
| SCHEMBL29608943 | 0.81 | RXRA (0.42) | HTR2ANOTUMKDM1A | |
| Benzene SCHEMBL1140991 | 0.79 | RXRA (0.44) | — | |
| SCHEMBL11522414 | 0.78 | HTR2A (0.35) | HTR2ANOTUMKDM1A | |
| SCHEMBL7789722 | 0.78 | HTR2A (0.35) | HTR2ANOTUMKDM1AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0842928-B1 | PROCESS FOR PRODUCING ISOCHROMAN COMPOUNDS | KAO CORP (JP) | 2001-10-24 | — | — | EP | claimed |
| US-5912362-A | Process for preparing isochroman compounds | KAO CORPORATION (JP) | 1999-06-15 | — | — | US | claimed |
| EP-0842928-A1 | PROCESS FOR PRODUCING ISOCHROMAN COMPOUNDS | Kao Corporation (JP) | 1998-05-20 | — | — | EP | claimed |
| US-4541948-A | Perfumes containing polyalkyl substituted indan-1-ones and process for preparing the compounds | P. Robertet & Cie [Societe Anomyme] (FR) | 1985-09-17 | — | — | US | claimed |
| EP-0089302-B1 | SUBSTITUTED POLYALKYLATED DERIVATIVES OF 1-INDANONES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PERFUMES | P. ROBERTET & Cie Société Anonyme dite (FR) | 1985-09-11 | — | — | EP | claimed |
| JP-8301863-A | — | — | None | — | — | JP | disclosed |
| US-20260150572-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-28 | — | — | US | disclosed |
| US-20240260448-A1 | Metal Complexes | UDC IRELAND LIMITED (IE) | 2024-08-01 | — | — | US | disclosed |
| WO-2024143273-A1 | RESIN FILM, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | 株式会社レゾナック | 2024-07-04 | — | — | WO | disclosed |
| US-11917901-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-02-27 | — | — | US | disclosed |
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-06 | — | — | US | disclosed |
| WO-2022270546-A1 | NEGATIVE-TYPE PHOTOSENSITIVE POLYMER, POLYMER SOLUTION, NEGATIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, AND SEMICONDUCTOR DEVICE | 住友ベークライト株式会社 | 2022-12-29 | — | — | WO | disclosed |
| US-4980509-A | Aromatic polycyclic derivatives, their process of preparation and their use in human and veterinary medicine and in cosmetics | SOCIETE ANONYME DITE: L'OREAL (FR) | 1990-12-25 | — | — | US | disclosed |
| US-4898864-A | Bicyclic aromatic compounds, a process for their preparation and their use in cosmetics and human and veterinary medicine | L'OREAL (FR) | 1990-02-06 | — | — | US | disclosed |
| US-4826969-A | SKIN AND EYE DISORDERS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) | 1989-05-02 | — | — | US | disclosed |
| US-4541948-A | Perfumes containing polyalkyl substituted indan-1-ones and process for preparing the compounds | P. Robertet & Cie [Societe Anomyme] (FR) | 1985-09-17 | — | — | US | disclosed |
| US-4326055-A | ANTITUMOR AGENTS, SKIN DISORDERS, RHEUMATIC DISEASES | HOFFMANN-LA ROCHE INC. (US) | 1982-04-20 | — | — | US | disclosed |
| EP-0002742-B1 | STILBENE DERIVATIVES, THEIR PREPARATION AND MEDICINES CONTAINING THESE STILBENE DERIVATIVES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-04-14 | — | — | EP | disclosed |
| US-4193931-A | 7-(INDANYL OR NAPHTHYL)-3-METHYL-OCTA-2,4,6-TRIENE DERIVATIVES, ANTITUMOR | HOFFMANN-LA ROCHE INC. (US) | 1980-03-18 | — | — | US | disclosed |
| EP-0002742-A1 | Stilbene derivatives, their preparation and medicines containing these stilbene derivatives | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OTC, OCIAD1 | HTR2A 2863/4885NOTUM 230/4885KDM1A 2146/4885 |
| US-20260150572-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OPRD1, CHRND | HTR2A 4271/4885NOTUM 4355/4885KDM1A 3428/4885 |
| US-11917901-B2 | Metal complexes | MCOLN2, MCOLN1, AP1M1 | HTR2A 4427/4885NOTUM 4042/4885KDM1A 3005/4885 |
| US-20240260448-A1 | Metal Complexes | SOD1, AP1M1, AP3M1 | HTR2A 4632/4885NOTUM 3335/4885KDM1A 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.